StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Piperidine → (2S,3S,4R,5R)-5-{6-[(2,2-Diphenylethyl)amino]-2-[({[2-(1-piperidinyl)ethyl]sulfonyl}amino)methyl]-9H-purin-9-yl}-N-ethyl-3,4-dihydroxytetrahydro-2-furancarboxamide

HRID 1279213
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 1279213
Cl[CH2:2][CH2:3][S:4](Cl)(=[O:6])=[O:5].[NH2:8][CH2:9][C:10]1[N:18]=[C:17]2[C:13]([N:14]=[CH:15][N:16]2[C@@H:19]2[O:23][C@H:22]([C:24]([NH:26][CH2:27][CH3:28])=[O:25])[C@@H:21]([OH:29])[C@H:20]2[OH:30])=[C:12]([NH:31][CH2:32][CH:33]([C:40]2[CH:45]=[CH:44][CH:43]=[CH:42][CH:41]=2)[C:34]2[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=2)[N:11]=1.[NH:46]1[CH2:51][CH2:50][CH2:49][CH2:48][CH2:47]1>N1C=CC=CC=1.C(#N)C.C(OCC)(=O)C>[C:40]1([CH:33]([C:34]2[CH:35]=[CH:36][CH:37]=[CH:38][CH:39]=2)[CH2:32][NH:31][C:12]2[N:11]=[C:10]([CH2:9][NH:8][S:4]([CH2:3][CH2:2][N:46]3[CH2:51][CH2:50][CH2:49][CH2:48][CH2:47]3)(=[O:6])=[O:5])[N:18]=[C:17]3[C:13]=2[N:14]=[CH:15][N:16]3[C@@H:19]2[O:23][C@H:22]([C:24]([NH:26][CH2:27][CH3:28])=[O:25])[C@@H:21]([OH:29])[C@H:20]2[OH:30])[CH:45]=[CH:44][CH:43]=[CH:42][CH:41]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 3

HCID 8082PiperidineHCID 15385Ethanesulfonylchloride, 2-chloro-HCID 59909598(2S,3S,4R,5R)-5-{2-(aminomethyl)-6-[(2,2-diphenylethyl)amino]-9H-purin-9-yl}-N-ethyl-3,4-dihydroxytetrahydro-2-furancarboxamide

Produkt 1

HCID 59909591(2S,3S,4R,5R)-5-{6-[(2,2-Diphenylethyl)amino]-2-[({[2-(1-piperidinyl)ethyl]sulfonyl}amino)methyl]-9H-purin-9-yl}-N-ethyl-3,4-dihydroxytetrahydro-2-furancarboxamide
Ausbeute 2,6 %

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 1049PyridineLösungsmittelHCID 6342AcetonitrileLösungsmittelHCID 8857Ethyl AcetateLösungsmittel

Versuchsvorschrift

2-Chloroethanesulfonyl chloride (0.12 ml, 1.16 mmol) was added to a solution of (2S,3S,4R,5R)-5-{2-(aminomethyl)-6-[(2,2-diphenylethyl)amino]-9H-purin-9-yl}-N-ethyl-3,4-dihydroxytetrahydro-2-furancarboxamide (Preparation 27) (600 mg, 1.16 mmol) in a mixture of pyridine (2.5 ml ) and acetonitrile (10 ml). The reaction mixture was stirred for 1 hour at room temperature. Piperidine (1.0 ml, 10 mmol) was then added and the reaction mixture was heated under reflux for 16 hours. The reaction mixture was then diluted with ethyl acetate (50 ml) and washed with water (30 ml). The ethyl acetate layer was dried (anhydrous magnesium sulphate) and evaporated under reduced pressure. The residue was purified by column chromatography on silica gel eluting with dichloromethane:methanol:ammonia (95:5:0.5 by volume) increasing in polarity to dichloromethane:methanol:ammonia (90:10:1 by volume). The solvent was removed under reduced pressure and the residue repurified by column chromatography on silica gel eluting with ethyl acetate:methanol:ammonia (95:5:0.5 by volume) increasing in polarity to ethyl acetate:methanol:ammonia (90:10:1 by volume). The solvent was removed under reduced pressure and the residue was repurified by column chromatography on silica gel eluting with ethyl acetate:methanol (95:5 by volume) increasing in polarity to ethyl acetate:methanol (90:10 by volume) then ethyl acetate:methanol:ammonia (90:10:1 by volume). The solvent was removed under reduced pressure to give the title compound (21 mg).

Aufarbeitung

  1. temperaturethe reaction mixture was heated
  2. temperatureunder reflux for 16 hours
  3. washwashed with water (30 ml)
  4. dry with materialThe ethyl acetate layer was dried (anhydrous magnesium sulphate)
  5. customevaporated under reduced pressure
  6. customThe residue was purified by column chromatography on silica gel eluting with dichloromethane:methanol:ammonia (95:5:0.5 by volume)
  7. temperatureincreasing in polarity to dichloromethane:methanol:ammonia (90:10:1 by volume)
  8. customThe solvent was removed under reduced pressure
  9. customthe residue repurified by column chromatography on silica gel eluting with ethyl acetate:methanol:ammonia (95:5:0.5 by volume)
  10. temperatureincreasing in polarity to ethyl acetate:methanol:ammonia (90:10:1 by volume)
  11. customThe solvent was removed under reduced pressure
  12. customthe residue was repurified by column chromatography on silica gel eluting with ethyl acetate:methanol (95:5 by volume)
  13. temperatureincreasing in polarity to ethyl acetate:methanol (90:10 by volume)
  14. customThe solvent was removed under reduced pressure

Quellen und Nachweise

ORD-Eintrag
ord-7306d70bcbb34c3f8b691b0890d2e255
Quelldatensatz
uspto-grants-2002_09
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US06448236B1

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion